Balt Receives IDE Approval From the FDA to Begin the STEM Trial
IRVINE, Calif.--(BUSINESS WIRE)--Balt receives IDE approval from the FDA to begin the STEM Trial for the treatment of chronic Sub-Dural Hematoma (cSDH).
Copyright © 2021 Biotech Networks, LLC